Neurotech International Ltd. has received ethics approval to begin a pharmacokinetic study of its NTI164 drug in healthy adults, an important step for regulatory compliance in both the U.S. and ...
TipRanks on MSN
MicroPort NeuroTech steps up competition in brain vascular devices with new embolic agent trial
MicroPort NeuroTech Limited ($HK:2172) announced an update on their ongoing clinical study. Study Overview The clinical study “a Prospective, ...
Brain-computer interfaces (BCIs) have made their mark on medtech and Ability Neurotech hopes that its platform's unique ...
Neurotech International Ltd. (AU:NTI) has released an update. Neurotech International Ltd, a biopharmaceutical company specializing in paediatric neurological disorders, has solidified its partnership ...
Neurotech International Ltd. (AU:NTI) has released an update. Don't Miss our Black Friday Offers: Unlock your investing potential with TipRanks Premium - Now At 40% OFF! Make smarter investments with ...
CUMBERLAND, R.I.--(BUSINESS WIRE)--Neurotech Pharmaceuticals, Inc., an innovator in sustained drug delivery for chronic retinal diseases, announces that the U.S. Food and Drug Administration (FDA), ...
Stockhead on MSN
Neurotech receives positive opinion for orphan status in Rett Syndrome from European drug regulator
Neurotech receives positive opinion on orphan drug application in Europe Decision on orphan drug designation for NTI164 to ...
Ketamine has been the subject of research in recent years, highlighting its potential to treat and cure depression. The U.S. Food and Drug Administration (FDA) authorized Kernel, a neurotech company ...
Neurotech International Ltd. (AU:NTI) has released an update. Don't Miss our Black Friday Offers: Unlock your investing potential with TipRanks Premium - Now At 40% OFF! Make smarter investments with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback